US Tariffs May Delay New Drug Introductions; Experts Urge Reducing Old Drug Spending to Spur Growth
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Experts warn that US tariff policies could delay the introduction of new drugs in Taiwan. They recommend reducing spending on off-patent old drugs and optimizing the healthcare budget to accelerate innovative medical treatments.